health
Eli Lilly's Inluriyo-Verzenio Combo Gets USFDA Nod for ESR1-Mutated Metastatic Breast Cancer

Bengaluru: The US FDA has approved Eli Lilly's drug combination to treat adults with a type of advanced breast cancer that has spread to other parts of the body, the drugmaker said on Friday.The...
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
What happens when middle-aged adults take creatine for 12 weeks? New study finds muscle gains even without structured exercise
The Economic Times

Study Links Oral Menopausal Hormone Therapy to Thrombotic Risk
Drug Topics

Smartphone retinal imaging could expand global eye care screening
News-Medical

Why does endometriosis only cause major pain for some?
Futurity

Are You Always Up Past Midnight? Study Reveals How Sleeping Late May Affect Your Body’s Cancer Defences
News18